• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

People experiencing relatively mild cases of mental ill-health may be perceived differently by others depending on whether or not diagnostic labels are provided

by
August 28, 2024
in Health
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Diagnostic labels for people experiencing what some consider to be relatively milder forms of mental-ill health may affect how others perceive them for better and worse, according to a study published August 28, 2024 in the open-access journal PLOS Mental Health by Nick Haslam from the University of Melbourne, Australia, and colleagues.

People experiencing relatively mild cases of mental ill-health may be perceived differently by others depending on whether or not diagnostic labels are provided

Credit: Gordon Johnson

Diagnostic labels for people experiencing what some consider to be relatively milder forms of mental-ill health may affect how others perceive them for better and worse, according to a study published August 28, 2024 in the open-access journal PLOS Mental Health by Nick Haslam from the University of Melbourne, Australia, and colleagues.

In recent years, there’s been a general shift to increased diagnoses of mental ill-health. Here, Haslam and colleagues investigate the implications of diagnosing individuals presenting with mild or marginal symptoms. In this research, symptoms were judged to be mild or marginal by members of the public who rated different examples ranging in severity from clearly below to clearly above the diagnostic threshold as determined by a scale in a prior study.

Haslam and colleagues provided research participants (who were U.S. adults recruited from an online platform) with short vignettes describing people presenting with mild or marginal symptoms of different mental illnesses. 261 participants in Study 1 were given three labeled (“This person has a diagnosis of ___”) or unlabeled vignettes describing people presenting with symptoms of major depressive disorder (MDD), bipolar disorder (BD), or generalized anxiety disorder (GAD). 684 participants in Study 2 were given one labeled or unlabeled vignette describing someone presenting with either post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), or binge-eating disorder (BED). Participants were asked about their empathy for the described individual, their support in offering accommodations (e.g. “This person’s employer should not hesitate to offer them extra time to complete work-related tasks”), their suitability for mental health treatment, the persistence of their difficulties (e.g. “This person is likely to fully recover from their problems.”), and their identity (e.g. “This person’s problems are an important part of who they are” (Study 2 only)).

In Study 1, labeled individuals tended to elicit more empathy and be seen as more suitable for treatment versus unlabeled individuals, but were also believed to have more persistent problems. Study 2 differed from Study 1 in that there was no significant difference between empathy for labeled versus unlabeled individuals, but it also found that labelled individuals were seen to have less capacity to overcome their problems. Participants’ ratings varied significantly depending on the described disorder, with MDD and PTSD eliciting especially high empathy and accommodation support.

The results suggest that expansive diagnostic concepts that include relatively mild symptoms may promote help-seeking, empathy, and support, but also undermine perceived agency and expectations that problems can be overcome. It’s critical to remember that the severity of symptoms of individuals with the conditions referred to in this study can change over time and “mild” is subjective. Additionally, the choice to obtain or choose a diagnostic label is a personal one and varies between individuals, conditions and communities.

The authors add: “Applying diagnostic labels to relatively mild forms of distress has mixed blessings. Our research shows that it can increase empathy and support for the person, but also make their problems seem out of their control and harder to overcome.”

#####

In your coverage please use this URL to provide access to the freely available article in PLOS Mental Health: https://journals.plos.org/mentalhealth/article?id=10.1371/journal.pmen.0000096        

Citation: Altmann B, Fleischer K, Tse J, Haslam N (2024) Effects of diagnostic labels on perceptions of marginal cases of mental ill-health. PLOS Ment Health 1(3): e0000096. https://doi.org/10.1371/journal.pmen.0000096

Author Countries: Australia

Funding: This work was supported by Australian Research Council Discovery Project DP210103984 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLOS Mental Health

DOI

10.1371/journal.pmen.0000096

Method of Research

Experimental study

Subject of Research

People

COI Statement

Competing Interests: The authors have declared that no competing interests exist.

Share12Tweet7Share2ShareShareShare1

Related Posts

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

August 21, 2025
Anxiety, Anxiety Medications Linked to Parkinson’s Risk

Anxiety, Anxiety Medications Linked to Parkinson’s Risk

August 21, 2025

Combination Therapy Enhances Treatment Outcomes in Advanced Triple-Negative Breast Cancer

August 21, 2025

Ambient Documentation Technologies Alleviate Physician Burnout and Rekindle Joy in Medical Practice

August 21, 2025

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Forces Within Tissues Sculpt Developing Organs

STN1 Drives Pancreatic Cancer Metastasis via ZEB1

Anxiety, Anxiety Medications Linked to Parkinson’s Risk

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.